Patent ID: 8816119
Filing Date: 2014-08-26
Classification: A61K,A61P,C07C,C07D

Abstract:
1. An arylamide derivative having formula (I) or pharmaceutically acceptable salts thereof or stereoisomers of Formula I; where R′ and R″ are each independently selected from the group consisting of H and alkyl; z is an integer 0 to 3; R1 is selected from the group consisting of H, halogen, (per)haloalkyl, hydroxy and (CH R2 is selected from the group consisting of H, alkyl, halogen, trifluoromethyl, (halo)alkyl, hydroxy and (CH R3 is selected from the group consisting of NO R4 and R5 are each independently selected from the group consisting of H, alkyl and halogen; R6-R10 are each independently selected from the group consisting of H, alkyl, halogen, (per)haloalkyl, CN, NO X is selected from the group consisting of O, S, S(O), SO R11 is selected from the group consisting of alkyl, alkenyl, (per)haloalkyl, haloalkenyl, alkyl-CN and an aryl, heteroaryl, aliphatic or heteroaliphatic, 5-7-membered ring optionally substituted with 1-5 substituents selected from the group consisting of alkyl, halogen, (per)haloalkyl, CN, NO